SAN JOSE, Calif., May 2, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will be presenting at the 20th Annual B. Riley FBR Institutional Investor Conference to be held...
from PR Newswire: https://prn.to/2WlhSr5
No comments:
Post a Comment